Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach
Daniela Stols‐Gonçalves, Anne Linde Mak, Mette Simone Aae Madsen, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 22
Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma
Suki Ha, Vincent Wai‐Sun Wong, Xiang Zhang, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 141-152
Closed Access | Times Cited: 20
Multidimensional Interactive Cascading Nanochips for Detection of Multiple Liver Diseases via Precise Metabolite Profiling
Zhiyu Li, Weili Peng, Juan Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 9
The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective
Xingtong Lin, Hui Han, Nan Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7175-7175
Open Access | Times Cited: 8
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Shijiao Hou, Jiachen Yu, Yongshuang Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
The role of the microbiome in liver disease
David Schöler, Bernd Schnabl
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 3, pp. 134-142
Closed Access | Times Cited: 7
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 620-648
Open Access | Times Cited: 6
Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
Qingyi Mao, Beibei Lin, Wenluo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Efficacy and compatibility mechanism of bear bile powder in Shexiang Tongxin dropping pills for acute myocardial infarction treatment
Yu Luo, Fangmin Zhang, Lidan Zhu, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Quercetin‐Driven Akkermansia Muciniphila Alleviates Obesity by Modulating Bile Acid Metabolism via an ILA/m6A/CYP8B1 Signaling
Jiaqi Liu, Youhua Liu, Chaoqun Huang, et al.
Advanced Science (2025)
Open Access
Immunogenic shift of arginine metabolism triggers systemic metabolic and immunological reprogramming to suppress HER2 + breast cancer
Vandana Sharma, Veani Fernando, Xunzhen Zheng, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access
Epigenetic modifications in drug‐induced liver injury: A systematic review
Romina Lorena de los Santos‐Fernández, Antonio Segovia‐Zafra, Guillermo Paz‐López, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
New aspects characterizing non-obese NAFLD by the analysis of the intestinal flora and metabolites using a mouse model
Wenji Zhang, Wenli Cheng, JingHui Li, et al.
mSystems (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 4
Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity
Hong‐Tai Tzeng, Wei‐Chia Lee
Nutrients (2024) Vol. 16, Iss. 9, pp. 1388-1388
Open Access | Times Cited: 4
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
Elisa Monti, Clara Vianello, Ilaria Leoni, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 84-84
Open Access
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
Farah Abdelhameed, A.I. Mustafa, Chris Kite, et al.
Livers (2025) Vol. 5, Iss. 1, pp. 11-11
Open Access
Research Progress of Non-Alcoholic Fatty Liver Disease from the Perspective of Intestinal Flora
雪 罗
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 477-490
Closed Access
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease
I‐Wen Wu, Yu-Chieh Liao, Tsung-Hsien Tsai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Intestinal Microbiota Modulation by Fecal Microbiota Transplantation in Nonalcoholic Fatty Liver Disease
Goran Hauser, Indira Benjak Horvat, Mirjana Rajilić–Stojanović, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 779-779
Open Access
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Vicky Yao, Nairui Fan, Shuxia Ma, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
Updated Insights into Probiotics and Hepatobiliary Diseases
Xiaoyu Xu, Cheng Zhang, Guo‐Yi Tang, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 515-515
Open Access | Times Cited: 3
Response surface methodology optimization of extraction and enrichment conditions of total triterpenoid saponins from Celosiae Semen and evaluation of its lipid‐lowering activity
Lulu Yang, Qi‐Qi Zhou, Song Fan, et al.
Biomedical Chromatography (2024) Vol. 38, Iss. 5
Closed Access | Times Cited: 2
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease
Haojie Zhong, Yu-Pei Zhuang, Xinqiang Xie, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
N6-methyladenosine demethylase FTO regulates neuronal oxidative stress via YTHDC1-ATF3 axis in arsenic-induced cognitive dysfunction
Lixiao Zhou, Renjie Li, Fu Wang, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 135736-135736
Closed Access | Times Cited: 2
Microbiome signature suggestive of lactose-intolerance in rhesus macaques (Macaca mulatta) with intermittent chronic diarrhea
Annemiek Maaskant, Bas Voermans, Evgeni Levin, et al.
Animal Microbiome (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top